Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1Head & Neck 1Classical hematology 1

Conditions

Rectal Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 154Fluorouracil 138Gemcitabine 119Bevacizumab 115Leucovorin 106Specimen Handling 105Capecitabine 96pembrolizumab 90Magnetic Resonance Spectroscopy 82Nivolumab 80Cisplatin 80Irinotecan 72durvalumab 63Cetuximab 62Paclitaxel 60Biopsy 60130-nm albumin-bound paclitaxel 58Radiotherapy 49atezolizumab 44Albumin-Bound Paclitaxel 38Taxes 36Carboplatin 36Folfox protocol 34Drug Therapy 33lenvatinib 29dehydroftorafur 29sintilimab 28Cyclophosphamide 28tislelizumab 27Radiation 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Metronidazole × Gastrointestinal × 90 days × Clear all
NCT06728072 2026-05-06

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Virginia Commonwealth University

Phase 2 Recruiting
97 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06569368 2026-04-16

Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy

M.D. Anderson Cancer Center

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡